Skip to content

A TSX-listed commercial-stage pharmaceutical company, Acerus Pharmaceuticals has a vision to become a leading specialty pharmaceutical company focused on urology and Men’s Health with its nasal testosterone treatment, Natesto.

BMEX Gold (TSX-V:BMEX): Entering a...
Junior Canadian gold exploration company BMEX Gold...
Baselode Energy Corp (TSX-V:FIND): Opportunities...
A new company in the high-grade uranium...
Voyager Digital Ltd (FSE:USD2 |...
A public, licensed crypto-asset broker that provides...
Carrara Investment Management (ASX:CLF): Delivering...
A newly-formed investment management business, Carrara Investment...
XORTX Therapeutics (FRA:ANU1 | CSE:XRX...
A publicly-listed biopharmaceutical company with three clinically...
AdAlta Ltd (ASX:1AD) : Growing...
An ASX-listed innovative biotech company supported by...
Statistics showing how the WordPress...
Since the launch of its original version...
Hong Kong citizens seek a...
As China moves to reintegrate Hong Kong,...
Reforming the current dislocation of...
Mark Twain once famously quipped “history doesn’t...
The grey zone: How business...
In the late 1930s the business model...
Enabling global research excellence: Reaching...
Research and Development is big business. Global...
Artificial Intelligence (AI) and its...
As with almost all developing technologies, Artificial...

Subscribe FOR FREE TODAY

Receive each quarterly edition of Boardroom Broadcasts for free by signing up to our email newsletter.